The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective study of anti-mullerian hormone (AMH) as a predictor of chemotherapy-induced menopause.
 
Bogda Koczwara
No Relationships to Disclose
 
Shahid Ullah
No Relationships to Disclose
 
M Nazim Abbas
No Relationships to Disclose
 
Alex Scott-Hoy
No Relationships to Disclose
 
Fiona Young
No Relationships to Disclose
 
Ganessan Kichenadasse
No Relationships to Disclose
 
Christos Stelios Karapetis
Honoraria - MSD
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Roche
 
Amitesh Chandra Roy
No Relationships to Disclose
 
Shawgi Sukumaran
No Relationships to Disclose
 
David M. Ross
Honoraria - Bristol-Myers Squibb; Celgene; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Research Funding - Abbvie (Inst); ASLAN Pharmaceuticals (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Imago Pharma (Inst); NOHLA Therapeutics (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
 
Muhammad Adnan Khattak
Honoraria - Merck Serono; MSD Oncology; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
Speakers' Bureau - Merck Serono; MSD Oncology; Novartis
Research Funding - MSD Oncology
Travel, Accommodations, Expenses - Amgen; Merck Serono; MSD Oncology
 
Elinor Atkinson
No Relationships to Disclose
 
Hilary Martin
Honoraria - Amgen (I); BMS Brazil (I); Merck (I); MSD (I); Pfizer (I)
Consulting or Advisory Role - Bristol-Myers Squibb (I); Merck (I)
Speakers' Bureau - Bristol-Myers Squibb (I); Merck (I); MSD (I)
Research Funding - MSD
Travel, Accommodations, Expenses - Amgen; Amgen (I); Bristol-Myers Squibb; Bristol-Myers Squibb (I); Merck; Merck (I); MSD; MSD (I); Roche; Roche (I)